Standard BioTools Net Income 2011-2025 | LAB
Standard BioTools net income from 2011 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Standard BioTools Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-185 |
| 2023 | $-75 |
| 2022 | $-190 |
| 2021 | $-59 |
| 2020 | $-53 |
| 2019 | $-65 |
| 2018 | $-59 |
| 2017 | $-61 |
| 2016 | $-76 |
| 2015 | $-53 |
| 2014 | $-53 |
| 2013 | $-17 |
| 2012 | $-19 |
| 2011 | $-32 |
| 2010 | $-17 |
|
Standard BioTools Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-35 |
| 2025-06-30 | $-33 |
| 2025-03-31 | $-26 |
| 2024-12-31 | $-34 |
| 2024-09-30 | $-27 |
| 2024-06-30 | $-46 |
| 2024-03-31 | $-78 |
| 2023-12-31 | $-20 |
| 2023-09-30 | $-21 |
| 2023-06-30 | $-17 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $-21 |
| 2022-09-30 | $-29 |
| 2022-06-30 | $-64 |
| 2022-03-31 | $-76 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-18 |
| 2020-09-30 | $-6 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-13 |
| 2019-09-30 | $-13 |
| 2019-06-30 | $-14 |
| 2019-03-31 | $-25 |
| 2018-12-31 | $-15 |
| 2018-09-30 | $-15 |
| 2018-06-30 | $-16 |
| 2018-03-31 | $-13 |
| 2017-12-31 | $-10 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-17 |
| 2017-03-31 | $-17 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-20 |
| 2016-06-30 | $-19 |
| 2016-03-31 | $-20 |
| 2015-12-31 | $-13 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-16 |
| 2014-12-31 | $-11 |
| 2014-09-30 | $-14 |
| 2014-06-30 | $-13 |
| 2014-03-31 | $-15 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-4 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-7 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-7 |
| 2011-03-31 | $-17 |
| 2010-12-31 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.435B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.08 |
| Hims & Hers Health (HIMS) | United States | $9.340B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.882B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.377B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Enovis (ENOV) | United States | $1.605B | 8.43 |
| Omnicell (OMCL) | United States | $1.601B | 32.73 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.565B | 113.67 |
| Butterfly Network (BFLY) | United States | $0.563B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.295B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |